ATE345344T1 - (oxopyrazolo 1,5aöpyrimidin-2-yl) alkylcarbonsäureamide - Google Patents
(oxopyrazolo 1,5aöpyrimidin-2-yl) alkylcarbonsäureamideInfo
- Publication number
- ATE345344T1 ATE345344T1 AT02728576T AT02728576T ATE345344T1 AT E345344 T1 ATE345344 T1 AT E345344T1 AT 02728576 T AT02728576 T AT 02728576T AT 02728576 T AT02728576 T AT 02728576T AT E345344 T1 ATE345344 T1 AT E345344T1
- Authority
- AT
- Austria
- Prior art keywords
- sub
- oxopyrazolo
- carbonic acid
- acid amides
- alkyl carbonic
- Prior art date
Links
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 title 1
- 241001465754 Metazoa Species 0.000 abstract 2
- 210000003169 central nervous system Anatomy 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229960003692 gamma aminobutyric acid Drugs 0.000 abstract 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 abstract 2
- SVUOLADPCWQTTE-UHFFFAOYSA-N 1h-1,2-benzodiazepine Chemical compound N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 abstract 1
- 229940049706 benzodiazepine Drugs 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 244000144972 livestock Species 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27914701P | 2001-03-27 | 2001-03-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE345344T1 true ATE345344T1 (de) | 2006-12-15 |
Family
ID=23067823
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02728576T ATE345344T1 (de) | 2001-03-27 | 2002-03-27 | (oxopyrazolo 1,5aöpyrimidin-2-yl) alkylcarbonsäureamide |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US6703393B2 (de) |
| EP (1) | EP1392692B1 (de) |
| JP (1) | JP2004525937A (de) |
| AT (1) | ATE345344T1 (de) |
| BR (1) | BR0208241A (de) |
| CA (1) | CA2441926A1 (de) |
| DE (1) | DE60216083T2 (de) |
| ES (1) | ES2276936T3 (de) |
| MX (1) | MXPA03008681A (de) |
| WO (1) | WO2002076987A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0303910D0 (en) * | 2003-02-20 | 2003-03-26 | Merck Sharp & Dohme | Therapeutic agents |
| WO2005108401A1 (en) * | 2004-04-29 | 2005-11-17 | Dov Pharmaceutical, Inc. | 2-pyridinyl[7-(substituted-pyridin-4-yl) pyrazolo[1,5-a]pyrimidin-3-yl]methanones |
| US10954231B2 (en) | 2006-10-16 | 2021-03-23 | Bionomics Limited | Anxiolytic compounds |
| US8293737B2 (en) | 2006-10-16 | 2012-10-23 | Bionomics Limited | Anxiolytic compounds |
| AU2012222874B2 (en) | 2011-03-02 | 2015-04-16 | Bionomics Limited | Novel small-molecules as therapeutics |
| US9133188B2 (en) | 2011-05-12 | 2015-09-15 | Bionomics Limited | Methods for preparing naphthyridines |
| EP2674434A1 (de) * | 2012-06-11 | 2013-12-18 | Ares Trading S.A. | Tetraaza-Cyclopenta[a]indenyl und seine Verwendung als positive allosterische Modulatoren |
| AU2012357169B2 (en) * | 2011-12-22 | 2017-03-30 | Merck Patent Gmbh | Tetraaza-cyclopenta[a]indenyl and their use as positive allosteric modulators |
| US20150374705A1 (en) | 2012-02-14 | 2015-12-31 | Shanghai Institues for Biological Sciences | Substances for treatment or relief of pain |
| JP2018076234A (ja) * | 2015-03-16 | 2018-05-17 | 大正製薬株式会社 | ピラゾロ［１，５−ａ］ピリミジン化合物 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2157285B (en) * | 1984-04-11 | 1987-10-28 | Erba Farmitalia | 1h, 7h-pyrazolo1, 5-a pyrimidine-7-one derivatives and process for their preparation |
| US4950585A (en) * | 1987-08-18 | 1990-08-21 | Konica Corporation | Coupler for photographic use |
| EP0591528B1 (de) | 1991-04-22 | 1998-12-23 | Otsuka Pharmaceutical Factory, Inc. | PYRAZOLO[1,5-a]PYRIMIDINDERIVATE UND SIE ENTHALTENDE ANTIINFLAMMATORISCHE MITTEL |
| WO1997011946A1 (en) | 1995-09-28 | 1997-04-03 | Otsuka Pharmaceutical Factory, Inc. | Analgesics |
| US5723608A (en) | 1996-12-31 | 1998-03-03 | Neurogen Corporation | 3-aryl substituted pyrazolo 4,3-d!pyrimidine derivatives; corticotropin-releasing factor receptor (CRF1) specific ligands |
| US6271241B1 (en) | 1999-04-02 | 2001-08-07 | Neurogen Corporation | Cycloalkyl and aryl fused aminoalkyl-imidazole derivatives: modulators and GLP-1 receptors |
| US6358949B1 (en) | 1999-04-02 | 2002-03-19 | Neurogen Corporation | Aryl and hetroaryl fused aminoalkyl-imidazole derivatives: selective modulators of bradykinin B2 receptors |
| US6380210B1 (en) | 1999-04-02 | 2002-04-30 | Neurogen Corporation | Heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of GABAa receptors |
| AU2001236471A1 (en) | 2000-01-18 | 2001-07-31 | Neurogen Corporation | Imidazopyridines and related azacyclic derivatives as selective modulators of bradykinin b2 receptors |
| US6723332B2 (en) | 2000-05-26 | 2004-04-20 | Neurogen Corporation | Oxomidazopyridine-carboxamides |
| AU2001270297A1 (en) | 2000-06-30 | 2002-01-14 | Neurogen Corporation | 2-phenylimidazo(1,2-a)pyridine derivatives: a new class of gaba brain receptor ligands |
| CA2419966A1 (en) | 2000-09-06 | 2002-03-14 | Neurogen Corporation | Aryl substituted tetrahydroindazoles and their use as ligands for the gaba-a receptor |
| CA2419958A1 (en) | 2000-09-06 | 2002-03-14 | Neurogen Corporation | Substituted fused pyrroleimines and pyrazoleimines |
| WO2003037900A2 (en) * | 2001-11-01 | 2003-05-08 | Icagen, Inc. | Pyrazolopyrimidines |
-
2002
- 2002-03-27 MX MXPA03008681A patent/MXPA03008681A/es active IP Right Grant
- 2002-03-27 DE DE60216083T patent/DE60216083T2/de not_active Expired - Fee Related
- 2002-03-27 CA CA002441926A patent/CA2441926A1/en not_active Abandoned
- 2002-03-27 EP EP02728576A patent/EP1392692B1/de not_active Expired - Lifetime
- 2002-03-27 BR BR0208241-1A patent/BR0208241A/pt not_active IP Right Cessation
- 2002-03-27 JP JP2002576245A patent/JP2004525937A/ja active Pending
- 2002-03-27 ES ES02728576T patent/ES2276936T3/es not_active Expired - Lifetime
- 2002-03-27 AT AT02728576T patent/ATE345344T1/de not_active IP Right Cessation
- 2002-03-27 US US10/107,790 patent/US6703393B2/en not_active Expired - Fee Related
- 2002-03-27 WO PCT/US2002/009339 patent/WO2002076987A1/en not_active Ceased
-
2004
- 2004-03-09 US US10/796,509 patent/US7008947B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US7008947B2 (en) | 2006-03-07 |
| US20040176397A1 (en) | 2004-09-09 |
| ES2276936T3 (es) | 2007-07-01 |
| MXPA03008681A (es) | 2004-04-02 |
| CA2441926A1 (en) | 2002-10-03 |
| JP2004525937A (ja) | 2004-08-26 |
| WO2002076987A1 (en) | 2002-10-03 |
| US6703393B2 (en) | 2004-03-09 |
| BR0208241A (pt) | 2004-04-13 |
| EP1392692B1 (de) | 2006-11-15 |
| EP1392692A1 (de) | 2004-03-03 |
| DE60216083T2 (de) | 2007-06-28 |
| US20030109536A1 (en) | 2003-06-12 |
| DE60216083D1 (de) | 2006-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE168007T1 (de) | Zur behandlung von erkrankungen des zentralnervensystems verwendbare benzimidazole | |
| IS6459A (is) | Arýl sambrædd azapólýsýklísk efnasambönd | |
| IL134089A0 (en) | 1-(n-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of the phenyl ring | |
| CY1111951T1 (el) | Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου | |
| DE60204823D1 (de) | Heterocyclo-alkylsulfonyl Pyrazole als entzündungshemmende/analgetische Mittel | |
| DE60012751D1 (de) | Verwendung von ep4 rezeptorliganden zur behandlung von neuropathischen schmerz | |
| ATE345344T1 (de) | (oxopyrazolo 1,5aöpyrimidin-2-yl) alkylcarbonsäureamide | |
| CA2343459A1 (en) | Pyrazole derivatives as anti-inflammatory/analgesic agents | |
| CY1119257T1 (el) | Θεραπεια του νευροπαθητικου πονου με ανταγωνιστες υποδοχεα δεξτρομεθορφανης n-meθυλ-d-ασπαρτικων (nmda) | |
| EP1448193A4 (de) | Therapeutische verbindungen zur behandlung von dyslipidämischen zuständen | |
| BR0202546A (pt) | Sulfonil-heteroariltriazóis como agentes antiinflamatórios/analgésicos | |
| WO2004031174A8 (en) | Imidazol-1-ylmethyl pyridazine derivatives | |
| AU2003276514A1 (en) | 4-imidazol-1-ylmethyl-pyrimidine derivatives_as ligands for gabaa receptors | |
| ATE250027T1 (de) | Azetidincarboxamidderivate zur behandlung von zns-erkrankungen | |
| PT1308446E (pt) | 5-(alquilideno-cicloalquil) - e 5-(alquilideno- heterociclil) pirazoles | |
| BR0204547A (pt) | Pirazóis de 5-heteroátomo-substituìdo | |
| FR2860391B1 (fr) | Animaux transgeniques presentant les troubles majeurs lies a la maladie d'alzheimer | |
| DE69827706D1 (de) | 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems | |
| GB0003234D0 (en) | Method of treatment | |
| ATE220665T1 (de) | Azetidincarboxamidderivate zur behandlung von zns-erkrankungen | |
| DE69916577D1 (de) | Azetidincarboxamid-derivate zur behandlung von zns störungen | |
| DE60306918D1 (de) | Substituierte, ringkondensierte imidazolderivate: gabaa-rezeptorliganden | |
| TH51180A (th) | วิธีสำหรับการรักษาโรคพาร์คินสันโดยการให้ (-)-5- คีโท-2-N,N-ได-n-โปรพิลอะมิโน-เตตระไฮโดรเตตระลิน |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |